Latest SPL News

Page 2

Page 2 of 2

Starpharma Advances FDA Pathway and Expands Middle East Market with $20M Cash Buffer

Starpharma reports encouraging FDA feedback on its DEP® SN38 candidate for ovarian cancer and prepares for product launches in Saudi Arabia and UAE, supported by a solid $20.3 million cash position.

Ada Torres

29 Jan 2025